Free Trial
NYSEARCA:PBE

Invesco Biotechnology & Genome ETF (PBE) Price, Holdings, & News

$66.14 -1.17 (-1.74%)
As of 07/11/2025 04:10 PM Eastern

About Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Key Stats

Today's Range
$66.14
$66.79
50-Day Range
$59.58
$67.31
52-Week Range
$54.52
$72.84
Volume
3,055 shs
Average Volume
7,511 shs
Market Capitalization
$230.17 million
Assets Under Management
$229.54 million
Dividend Yield
0.24%
Net Expense Ratio
0.58%
Aggregate Rating
Moderate Buy

ETF Overview

Invesco Biotechnology & Genome ETF Expenses

TypePBEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.56%0.51%0.53%
Other Expenses0.08%0.47%0.56%0.59%0.56%
Total Expense0.58%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.58%0.60%0.63%0.58%0.60%
Receive PBE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.

PBE ETF News Headlines

PBE Invesco Biotechnology & Genome ETF
Invesco Dynamic Biotech & Genome ETF (PBE)
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

PBE ETF - Frequently Asked Questions

Invesco Biotechnology & Genome ETF's stock was trading at $66.53 on January 1st, 2025. Since then, PBE shares have decreased by 0.6% and is now trading at $66.14.

Top institutional investors of Invesco Biotechnology & Genome ETF include YHB Investment Advisors Inc. (0.70%) and Wealth Enhancement Advisory Services LLC (0.14%).

Shares of PBE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Biotechnology & Genome ETF investors own include Micron Technology (MU), Pfizer (PFE), Devon Energy (DVN), Intel (INTC), Activision Blizzard (ATVI), NVIDIA (NVDA) and Bristol Myers Squibb (BMY).

Fund Details

Issuer
Invesco
Fund Name
Invesco Biotechnology & Genome ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:PBE
Inception Date
6/23/2005
Fund Manager
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser

Fund Focus

Asset Class
Equity
Benchmark
Dynamic Biotech & Genome Intellidex Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
31

Fund Statistics

Assets Under Management
$233.59 million
Average Daily Volume
$5.48 thousand
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
10
Put Options
5
Call Options
10
Short Interest
500 shs

Miscellaneous

Beta
0.76
Creation Unit
10,000
Creation Fee
$500.00
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Top 10 PBE Holdings

PBE Sector Exposure

PBE Industry Exposure


This page (NYSEARCA:PBE) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners